Duearity
0.237 SEK +29.95%1 investor is following this company
Duearity operates in the medical technology industry. The company specializes in the development and production of technical solutions for the treatment and relief of tinnitus. The product portfolio includes, for example, the company's proprietary products Tinearity and Duearity. In addition to the main business, service and associated ancillary services are also offered. Duearity operates on the Swedish market.
Revenue
970K
EBIT %
-2,135.05 %
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
First North Stockholm
DEAR
Daily low / high price
0.184 / 0.28
SEK
Market cap
6.23M SEK
Turnover
133.07K SEK
Volume
568K
Latest videos
Financial calendar
Interim report
2024-08-22
Interim report
2024-11-28
Annual report
2025-02-27
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Footloose Invest AB | 22.2 % | 22.2 % |
JeGol Group AB | 9.0 % | 9.0 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
Årsstämma i Duearity AB (PUBL) den 29 juni 2024
Valberedningens förslag till styrelseledamöter i Duearity AB
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools